July 23-24, 2022
LIVE AND IN-PERSON
LIVE AND IN-PERSON
The Enbridge Tour Alberta for Cancer is in support of the most courageous and brave Albertans who have shown their Alberta strength through a cancer experience. Those with us. And those we’ve lost.
World Class Research and Care
Over the past five years, more than 5,500 of our fellow Albertans have taken part in 500 trials. The Alberta Cancer Foundation supports every cancer clinical trial that takes place in Alberta. Our province is emerging as a centre of research excellence, both nationally and internationally, for cancer clinical trials and funds raised through The Tour help bring the cancer treatments of tomorrow to Albertans facing cancer today. 1,171 Albertans gained access to a clinical trial in 2020/21. The most recently funded clinical trial is Dr. Michael Chu’s CAR-T Cell Therapy trial bringing the most cutting-edge immunotherapy treatment to Albertans. This groundbreaking clinical trial will benefit Albertans facing blood cancer who have no treatment options left by channeling the power of the immune system.
Alberta’s Cancer Centres
Supporting your local cancer centre through the Enbridge Tour Alberta for Cancer means you are helping health-care workers across Alberta with the resources they need to provide patients and their families with the best treatment and care available. Albertans helping Albertans.
Radiation therapy plays an important role in cancer treatment. It uses high energy waves to destroy cancerous cells and although it is effective, it can destroy healthy surrounding tissue and take several treatments over a long period of time. In this ever-evolving field, new radiation techniques have been developed thanks to leading-edge technology such as the Linac-MR. Merging the imaging abilities of an MRI system with the treatment capabilities of a Linear Accelerator, this made-in-Alberta machine will allow doctors to see and treat cancer with radiation using real-time MR imaging. By guiding and directing a radiation beam precisely at a tumour, the Linac-MR will allow treatment doses to be increased, the number of treatments required to be reduced, and cause significantly less damage to healthy tissues and organs. The Northern LIGHTs Program is a collection of clinical trials that will first test, and then provide Albertans facing cancer with access to the Linac-MR to receive cutting-edge radiation therapy treatments.